Evidence map›Paper›PMID 31484523›Full record

ArticleBMC health services research2019

Remote follow-up using patient-reported outcome measures in patients with chronic kidney disease: the PROKID study - study protocol for a non-inferiority pragmatic randomised controlled trial.

Birgith Engelst Grove, Per Ivarsen, Annette de Thurah, Liv Marit Schougaard, Derek Kyte, Niels Henrik Hjøllund

Registry-linked trialOpen access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in BMC health services research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03847766 (Tele Follow-up Using Patient-reported Outcomes), which is not on this map. Cited by 11 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 2 pooled it
6.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03847766 nacompletednot on this map

Tele Follow-up Using Patient-reported Outcomes (PRO) Measures in Patients With Chronic Kidney Disease - the PROKID Study

TypeinterventionalSponsorUniversity of AarhusRan2018 to 2023Enrolled152ConditionsChronic Kidney DiseasesArmsPRO-based follow-up, PRO-based telephone consultation
3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 2 syntheses or guidelines pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Review
  7. Patient-reported outcome (PRO) measurements in chronic and malignant diseases: ten years' experience with PRO-algorithm-based patient-clinician interaction (telePRO) in AmbuFlex.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2023
    Article
  8. Review
  9. Review
  10. Article
  11. Management of transplant patients outside hospital during COVID-19 epidemic: A Chinese experience.Transplant infectious disease : an official journal of the Transplantation Society · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Birgith Engelst GroveAmbuFlex/WestChronic, Occupational Medicine, University Research Clinic, Aarhus University, Herning, Denmark. bigcri@rm.dk.ORCID http://orcid.org/0000-0002-3763-9911
Per IvarsenDepartment of Nephrology, Aarhus University Hospital, Aarhus, Denmark.
Annette de ThurahDepartment of Rheumatology, Aarhus University Hospital, Aarhus, Denmark.
Liv Marit SchougaardAmbuFlex/WestChronic, Occupational Medicine, University Research Clinic, Aarhus University, Herning, Denmark.
Derek KyteHealth Research Methods, Centre for Patient-Reported Outcomes Research (CPROR), Institute of Applied Health Research, University of Birmingham, Birmingham, UK.
Niels Henrik HjøllundAmbuFlex/WestChronic, Occupational Medicine, University Research Clinic, Aarhus University, Herning, Denmark.
Aarhus University · DKAarhus University Hospital · DKUniversity of Birmingham · GB

Funding

Department of Health PDF-2016-09-009Helsefonden 18-B-0039Karen Elise Jensens Fond 23-3-2018TrygFonden 124259
6 · The paper itself

Abstract

backgroundOutpatient care is steadily changing from hospital consultations to other platforms, such as phone consultation and online virtual clinics. It is prudent to maintain quality of care with such initiatives. Currently, patients with chronic kidney disease (CKD) have frequent scheduled visits, but it may be possible to optimise the frequency of hospital consultations using information from patient-reported outcome (PRO) questionnaires filled in at home (PRO-based follow-up). This approach may provide a more individually tailored follow-up based on actual needs for clinical attention. We aimed to evaluate the effectiveness of the quality of care, use of resources and patient outcomes associated with PRO-based follow-up in patients with CKD.

methodsThis study is a pragmatic, non-inferiority, randomised controlled trial in outpatients with CKD (Grove BE et al., Qual Life Res 27: S143, 2018). Newly referred patients with an estimated glomerular filtration rate (eGFR) of ≤40 ml/min 1.73m DISCUSSION: Benefits and possible drawbacks of the PRO-based follow-up will be evaluated. If PRO-based follow-up proves non-inferior to usual outpatient follow-up, a reorganisation of routine clinical practice in nephrology outpatient clinics may occur. Further, results may impact other patient groups with chronic conditions attending regular follow-up.

trial registrationClinicalTrials.gov identifier NCT03847766 (Retrospectively registered on January 23, 2019).

Indexed as

Remote ConsultationAmbulatory CareFemaleFollow-Up StudiesHumansMalePatient Reported Outcome MeasuresRenal Insufficiency, ChronicRetrospective StudiesSurveys and QuestionnairesAmbulatory careChronic kidney diseaseOutpatient clinicPatient-reported outcome measuresRandomised controlled trial

Identifiers

PMID31484523
PMCPMC6727325
OpenAlexW2972113810

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.